Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 9, 2001, Pages 604-608

  Fung, Ellen B ^a   Barden, Elizabeth M ^a   Kawchak, Deborah A ^a   Zemel, Babette S ^a   Ohene Frempong, Kwaku ^a   Stallings, Virginia A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; Growth; Hydroxyurea; Nutrition; Resting energy expenditure; Sickle cell anemia

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ARTICLE; CHILD; CHILD GROWTH; CLINICAL ARTICLE; DIETARY INTAKE; DRUG EFFECT; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; HUMAN; MALE; NUTRITION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BASAL METABOLISM; CHILD; CHILD, PRESCHOOL; ENERGY INTAKE; FEMALE; FETAL HEMOGLOBIN; HUMANS; HYDROXYUREA; INFANT; MALE; NUTRITION DISORDERS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 0035693851     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200112000-00010     Document Type: Article

References (23)

1. Hoppe C, Styles L, Vichinsky E. The natural history of sickle cell disease. Curr Opin Pediatr 1998; 10: 49-52.
2. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991; 325: 11-6.
3. Gee BE, Platt OS. Growth and development. In: Embury SH, Hebbel RP, Mohandas N, et al, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press, 1994: 589-97.
4. Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell disease. Am J Hematol 1987; 24: 441-55.
5. Gray NT, Bartlett JM, Kolasa KM, et al. Nutritional status and dietary intake of children with sickle cell anemia. Am J Pediatr Hematol Oncol 1992; 14: 57-61.
6. Barden EM, Zemel BS, Kawchak DA, et al. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 2000; 136: 73-9.
7. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317-22.
8. Scott JP, Hillery CA, Brown ER, et al. Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 1996;128: 6: 820-8.
9. Jayabose S, Tugal O, Sandoval C, et al. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. J Pediatr 1996; 129: 559-65.
10. Ferster A, Vermylen C, Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 1996;88: 6: 1960-4.
11. Koren A, Segal-Kupershmit D, Zalman L, et al. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatr Hematol Oncol 1999;16: 3: 221-32.
12. Hackney AC, Hezier W, Gulledge TP, et al. Effects of hydroxyurea administration on the body weight, body composition and exercise performance of patients with sickle-cell anemia. Clin Sci 1997; 92: 481-6.
13. Kinney TR, Helms RW, O’Branski EE, et al. Safety of hydroxyurea with sickle cell anemia: results of the HUG-KIDS Study, a phase I/II trial. Blood 1999;94: 5: 1550-4.
14. Lohman T, Roche A, Martorell R. Anthropometric Standardization Reference Manual. Champaign, Illinois: Human Kinetics Books, 1981.
15. Brook G. Determination of body composition of children from skinfold measurements. Arch Dis Child 1971; 46: 182-9.
16. Hamill P, Drizd T, Johnson C, et al. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979; 32: 607-29.
17. Cole TJ. The use and construction of anthropometric growth reference standards. Nutr Res Rev 1993; 6: 19-50.
18. Frisancho A. Anthropometric Standards for the Assessment of Growth and Nutritional Status. Ann Arbor, MI: The University of Michigan Press, 1993.
19. World Health Organization. Energy and protein requirements: report of a joint FAO/WHO/UNU expert consultation. Geneva: World Health Organization, 1985.
20. Zemel BS, Kawchak DA, Cnaan A, et al. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function and genotype in children with cystic fibrosis. Pediatr Res 1996; 8: 578-86.
21. National Research Council. Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press, 1989.
22. Ballas SK, Marcolina MJ, Dover GJ, et al. Erythropoietic activity in patients with sickle cell anemia before and after treatment with hydroxyurea. Br J Haematol 1999;105: 2: 491-6.
23. de Montalembert M, Belloy M, Bernaudin F, et al. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. J Pediatr Hematol Oncol 1997; 19: 313-8.